Author:
OKHLOPKOV V A,MEDVEDCHIKOV E K,DOLGIKH T I,PRAVDINA O V,GORODILOV R V,ZARAYEVA I F
Abstract
The authors examined the clinical effect and dynamics of immunological indices (IL-1, IL-6, TNF-, IFN-) at the progressing
and stationary stages of psoriasis with the administration of Stemokin®. A reliable reduction of IL-1, TNF- и IFN- was observed
against the background of treatment and was accompanied with an evident clinical effect. Two variants of the immune system
response were revealed for the complex therapy.
Publisher
Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov
Reference21 articles.
1. Мордовцев В.Н., Суколин Г.И., Сергеев А.С. Эпидемиология и генетика псориаза. Симпозиум по псориазу дерматовенеро- логов социалистических стран, 3-й. М., 1987; 89.
2. Baker H. Psoriasisclinical features. Br Med J 1994; 3: 231-233.
3. Elder J.T., Henseler T., Christophers E. The genetis of psoriasis. Arch Dermatol 1994; 130: 216-224.
4. Farber E.M. Infantile psoriasis: a follow-up study. Pediatr Dermatol 1986; 3: 3: 237-243.
5. Matthews D., Powles A.V., Fry L., Williamson. Conformation of genetic heterogeneity in familial psoriais. J Invest Dermatol 1995; 105: 3: 457-461.